Cancer Services Breast Cancer Colon and Rectal Cancer Gynecology Cancer Head and Neck Cancer Lung Cancer Myeloma Orthopedic Cancer Skin Cancer Thyroid Cancer Urology Cancer
Myeloma Gareth Morgan, M.D., Ph.D. Director of the UAMS Myeloma Insititute Multiple myeloma is a type of cancer that affects the plasma cells. Nationwide, the median survival rate of patients with multiple myeloma is only about four years. But at our UAMS Myeloma Institute the survival rate is closer to eight or nine years, and [...]
Myeloma Patient Stories UAMS has the world's best treatment center for multiple myeloma. Our Myeloma Institute has seen more than 10,000 patients since its founding in 1989. A measure of how well we succeed is hearing stories like these from patients who were treated at UAMS. Myeloma Patient "In Good Hands" Claudia Jessup's life has taken [...]
Cancer Offering the expertise of specialists in various fields, our team members at the Winthrop P. Rockefeller Cancer Institute create the best personalized treatment plan for you. Providing this kind of customized care requires the kind of options that you will find only at an academic health care facility like UAMS. Breast Cancer Colon and [...]
UAMS -- University of Arkansas Medical Sciences At the University of Arkansas for Medical Sciences, we are the home of the state’s only academic health sciences center. With clinics covering nearly every medical specialty, our research and educational programs inspire new knowledge that results in better diagnosis and more advanced patient care. [...]
Defensive tackle for the Tampa Bay Buccaneers and Super Bowl XLVIII champion Clinton McDonald learned that he has something in common with UAMS Winthrop P. Rockefeller Cancer Institute patients when he paid them a visit last week — they are fighters.
Jan. 19, 2011 | Internationally known multiple myeloma researcher Frits van Rhee, M.D., Ph.D., was invested Jan. 17 as the inaugural recipient of the Charles & Clydene Scharlau Chair for Hematological Malignancies Research.
LITTLE ROCK – Internationally known multiple myeloma researcher Frits van Rhee, M.D., Ph.D., was invested today as the inaugural recipient of the Charles & Clydene Scharlau Chair for Hematological Malignancies Research.
LITTLE ROCK – Carol A. Ammon, of Wilmington, Del., founder and retired chief executive officer and chairman of Endo Pharmaceuticals Inc., has been named chairman of the advisory board for the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS). <br /> <br />
LITTLE ROCK – The internationally known Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS) marked another milestone today, treatment of the 10,000th patient in its 22-year history.